Immune-checkpoint inhibitor resistance in patients with cancer

The introduction of immune checkpoint inhibitors (ICIs) has transformed the landscape of oncology, offering significant improvements in patient survival and achieving remarkable long-term outcomes. Despite these advances, the therapeutic benefits of ICIs are not universal, and existing biomarkers of...

Full description

Saved in:
Bibliographic Details
Main Authors: Luis Cabezón-Gutiérrez, Sara Custodio-Cabello, Magda Palka-Kotlowska, Beatriz Chacón-Ovejero, Vilma Pacheco-Barcia
Format: Article
Language:English
Published: Open Exploration Publishing Inc. 2025-05-01
Series:Exploration of Immunology
Subjects:
Online Access:https://www.explorationpub.com/uploads/Article/A1003196/1003196.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!